Skip to main content

Table 1 Activation Profile of Opioid ligands in HEK-δ Cells

From: Activation profiles of opioid ligands in HEK cells expressing δ opioid receptors

LIGAND

IC50 ± SEM (nM)

Max Inhibition %

Butorphanol

61 ± 12

64 ± 4$

Cyclazocine

6 ± 3

53 ± 2**

Dezocine

477 ± 152

39 + 8

Etorphine

0.2 ± 0.1

67 ± 3$$

Fentanyl

2039 ± 554

71 ± 7$$ #

Hydromorphone

54 ± 31

65 ± 5$

Lofentanil

0.8 ± 0.4

62 ± 7$

Metazocine

159 ± 70

77 ± 4$$

Met-enkephalin

22 ± 17

49 ± 6##

Morphine

1101 ± 614

39 ± 4**

Nalbuphine

545 ± 378

55 ± 7*

Nalorphine

Antagonist

 

Naltrexone

Antagonist

 

SKF 10047

184 ± 121

68 ± 9$$

WIN 44,441

40 ± 25

54 ± 6*

Xorphanol

8 ± 2

76 ± 4$$ ##

  1. Inhibitory effect of opioid ligands on Forskolin-stimulated Adenylyl Cyclase activity was measured as described under Materials and Methods. Data for IC50's represent the mean ± SEM obtained from two or more experiments carried out in duplicate. Maximum inhibition is the mean ± SEM of maximum inhibition obtained from a best fit curve as described under "Materials and Methods" (** = P < 0.001, * = P < 0.05 compared to Metazocine), ($$ = P < 0.001, $ = P < 0.05 compared to morphine), (## = P < 0.001, # = P < 0.05 compared to met-enkephalin).